Genetic testing in pregnancy

Pregnancy is a time of intense emotions, including hope, but also natural concerns about the health of the baby. Modern medicine offers parents-to-be advanced tools to monitor fetal development early and safely. Non-invasive prenatal testing (NIPT), which analyses the free fetal DNA circulating in the mother's blood, plays a key role here. They provide valuable information about the baby's risk of multiple genetic defects without risk to the pregnancy. Among the most advanced and comprehensive NIPT tests, VERACITY and VERAgene stand out, offering a wide diagnostic range and high precision.

VERACITY study: Precision and Safety

VERCAITY is a state-of-the-art, non-invasive prenatal test that has gained recognition for its high accuracy (over 99% in detecting the most common trisomies) and safety. It only needs a small blood sample from the pregnant woman to be performed, eliminating the risks associated with invasive procedures such as amniocentesis

Veracity testing allows early detection of the risk of many genetic defects, including:

  • Autosomal trisomies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13)

  • Aneuploidies of the sex chromosomes, e.g. Turner syndrome (monosomy X), Klinefelter syndrome (XXY)

  • Selected microdeletions, i.e. defects in small chromosome fragments that can lead to serious syndromes (e.g. DiGeorge syndrome, Wolf-Hirschhorn syndrome)

For more information -> on VERACITY.

The VERACITY test can be performed as early as the 10th week of pregnancy and the results are usually available within several days. This gives the parents valuable time to possibly take further action and prepare for the future.

VERAgene test: Comprehensive DNA analysis of both parents

VERAgene is an innovative prenatal test that is an extended version of the VERACITY test, offering the widest diagnostic range among the available non-invasive NIPT tests. Its uniqueness lies in the fact that, in addition to analysing fetal DNA from the mother's blood, it also takes into account the genetic material of the biological father (collected by means of a cheek swab).

This additional analysis allows:

  • Detection of all abnormalities that the VERACITY test covers (trisomies, sex chromosome aneuploidies, microdeletions).

  • Identify the risk of fetal inheritance of more than 100 monogenic (single-gene) diseases, such as cystic fibrosis, phenylketonuria or sickle cell anaemia. This is particularly important if there is a family history of autosomal recessively inherited diseases, where the parents may be asymptomatic carriers.

  • The VERAgene test is particularly recommended for couples who want to gain the most comprehensive knowledge of their baby's genetic health early in pregnancy. Like VERACITY, it is safe, non-invasive and can be performed from the 10th week of pregnancy, providing precise results.

Choosing the right prenatal test is an important decision to make after consulting with your pregnancy doctor or geneticist. Both VERACITY and VERAgene are advanced tools that can bring peace of mind and reassurance to help you make informed decisions about your family's future.